164 related articles for article (PubMed ID: 3181200)
1. Growth response to growth hormone therapy following craniospinal irradiation.
Clayton PE; Shalet SM; Price DA
Eur J Pediatr; 1988 Aug; 147(6):597-601. PubMed ID: 3181200
[TBL] [Abstract][Full Text] [Related]
2. Growth response to growth hormone therapy following cranial irradiation.
Clayton PE; Shalet SM; Price DA
Eur J Pediatr; 1988 Aug; 147(6):593-6. PubMed ID: 3181199
[TBL] [Abstract][Full Text] [Related]
3. Treatment of radiation-induced growth hormone deficiency with growth hormone-releasing hormone.
Ogilvy-Stuart AL; Stirling HF; Kelnar CJ; Savage MO; Dunger DB; Buckler JM; Shalet SM
Clin Endocrinol (Oxf); 1997 May; 46(5):571-8. PubMed ID: 9231053
[TBL] [Abstract][Full Text] [Related]
4. Response to growth hormone treatment and final height after cranial or craniospinal irradiation.
Sulmont V; Brauner R; Fontoura M; Rappaport R
Acta Paediatr Scand; 1990 May; 79(5):542-9. PubMed ID: 2386044
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone therapy in children after cranial/craniospinal radiation therapy: sexually dimorphic outcomes.
Lerner SE; Huang GJ; McMahon D; Sklar CA; Oberfield SE
J Clin Endocrinol Metab; 2004 Dec; 89(12):6100-4. PubMed ID: 15579765
[TBL] [Abstract][Full Text] [Related]
6. Growth and puberty after growth hormone treatment after irradiation for brain tumours.
Ogilvy-Stuart AL; Shalet SM
Arch Dis Child; 1995 Aug; 73(2):141-6. PubMed ID: 7574858
[TBL] [Abstract][Full Text] [Related]
7. Growth and growth hormone secretion in children following treatment of brain tumours with radiotherapy.
Darendeliler F; Livesey EA; Hindmarsh PC; Brook CG
Acta Paediatr Scand; 1990 Oct; 79(10):950-6. PubMed ID: 2264467
[TBL] [Abstract][Full Text] [Related]
8. Growth response and final height in growth hormone-deficient patients treated with biosynthetic growth hormone.
Chen YD; Shu SG; Chi CS
Acta Paediatr Taiwan; 2001; 42(5):291-6. PubMed ID: 11729706
[TBL] [Abstract][Full Text] [Related]
9. Growth impairment and growth hormone therapy in children treated for malignant brain tumours.
Ilveskoski I; Saarinen UM; Wiklund T; Sipilä I; Mäkipernaa A; Perkkiö M; Lanning M; Salmi TT; Pihko H
Eur J Pediatr; 1997 Oct; 156(10):764-9. PubMed ID: 9365064
[TBL] [Abstract][Full Text] [Related]
10. Role of busulfan and total body irradiation on growth of prepubertal children receiving bone marrow transplantation and results of treatment with recombinant human growth hormone.
Giorgiani G; Bozzola M; Locatelli F; Picco P; Zecca M; Cisternino M; Dallorso S; Bonetti F; Dini G; Borrone C
Blood; 1995 Jul; 86(2):825-31. PubMed ID: 7606014
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone secretion and response to growth hormone therapy after treatment for brain tumour.
Lannering B; Marky I; Mellander L; Albertsson-Wikland K
Acta Paediatr Scand Suppl; 1988; 343():146-51. PubMed ID: 3143223
[TBL] [Abstract][Full Text] [Related]
12. Final height after combined growth hormone and gonadotrophin-releasing hormone analogue therapy in short healthy children entering into normally timed puberty.
Lanes R; Gunczler P
Clin Endocrinol (Oxf); 1998 Aug; 49(2):197-202. PubMed ID: 9828907
[TBL] [Abstract][Full Text] [Related]
13. Long-term results of growth hormone therapy in children with short stature, subnormal growth rate and normal growth hormone response to secretagogues. Dutch Growth Hormone Working Group.
Wit JM; Boersma B; de Muinck Keizer-Schrama SM; Nienhuis HE; Oostdijk W; Otten BJ; Delemarre-Van de Waal HA; Reeser M; Waelkens JJ; Rikken B
Clin Endocrinol (Oxf); 1995 Apr; 42(4):365-72. PubMed ID: 7750190
[TBL] [Abstract][Full Text] [Related]
14. Height prognosis of children with true precocious puberty and growth hormone deficiency: effect of combination therapy with gonadotropin releasing hormone agonist and growth hormone.
Cara JF; Kreiter ML; Rosenfield RL
J Pediatr; 1992 May; 120(5):709-15. PubMed ID: 1533661
[TBL] [Abstract][Full Text] [Related]
15. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
Mauras N; Attie KM; Reiter EO; Saenger P; Baptista J
J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
[TBL] [Abstract][Full Text] [Related]
16. Improvements in final height over 25 years in growth hormone (GH)-deficient childhood survivors of brain tumors receiving GH replacement.
Gleeson HK; Stoeter R; Ogilvy-Stuart AL; Gattamaneni HR; Brennan BM; Shalet SM
J Clin Endocrinol Metab; 2003 Aug; 88(8):3682-9. PubMed ID: 12915655
[TBL] [Abstract][Full Text] [Related]
17. Factors that affect final height and change in height standard deviation scores in survivors of childhood cancer treated with growth hormone: a report from the childhood cancer survivor study.
Brownstein CM; Mertens AC; Mitby PA; Stovall M; Qin J; Heller G; Robison LL; Sklar CA
J Clin Endocrinol Metab; 2004 Sep; 89(9):4422-7. PubMed ID: 15356041
[TBL] [Abstract][Full Text] [Related]
18. Adult height after growth hormone (GH) treatment for GH deficiency due to cranial irradiation.
Adan L; Sainte-Rose C; Souberbielle JC; Zucker JM; Kalifa C; Brauner R
Med Pediatr Oncol; 2000 Jan; 34(1):14-9. PubMed ID: 10611579
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone state after completion of treatment with growth hormone.
Clayton PE; Price DA; Shalet SM
Arch Dis Child; 1987 Mar; 62(3):222-6. PubMed ID: 3566314
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy with GH and cyproterone acetate does not improve final height in boys with non-GH-deficient short stature.
Kawai M; Momoi T; Yorifuji T; Muroi J; Yamanaka C; Sasaki H; Furusho K
Clin Endocrinol (Oxf); 1998 Jan; 48(1):53-7. PubMed ID: 9509068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
